{"DataElement":{"publicId":"3976711","version":"1","preferredName":"Hematopoietic Cell Graft Alteration Antibody Administered Type","preferredDefinition":"A description of the antibodies administered during the hematopoietic cell product (graft) manipulation.","longName":"3952433v1.0:3976692v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3952433","version":"1","preferredName":"Hematopoietic Cell Graft Alteration Antibody Administered","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._A change resulting in something that is different from the original._A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._The act of having given something (e.g., a medication or test).","longName":"3952431v1.0:2744937v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3952435","version":"1","preferredName":"Hematopoietic Stem Cell Graft Alteration Antibody","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.:A change resulting in something that is different from the original.:(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","longName":"C12551:C12981:C28344:C16295","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Alteration","conceptCode":"C28344","definition":"The act or process of modifying something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3715B4-3104-749A-E040-BB89AD430AED","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-15","modifiedBy":"ONEDATA","dateModified":"2013-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB3715B4-30CB-749A-E040-BB89AD430AED","latestVersionIndicator":"Yes","beginDate":"2013-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3976692","version":"1","preferredName":"Antibody Type","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen._Something distinguishable as an identifiable class based on common qualities.","longName":"3976692v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other antibody","valueDescription":"Other Antibody","ValueMeaning":{"publicId":"3976693","version":"1","preferredName":"Other Antibody","longName":"3976693","preferredDefinition":"Different than the one(s) previously specified or mentioned.: (AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECB94912-471A-A389-E040-BB89AD434D76","latestVersionIndicator":"Yes","beginDate":"2013-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ECB94912-4733-A389-E040-BB89AD434D76","beginDate":"2013-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-04","modifiedBy":"ONEDATA","dateModified":"2013-12-04","deletedIndicator":"No"},{"value":"Anti CD52","valueDescription":"Anti-CD52","ValueMeaning":{"publicId":"4000138","version":"1","preferredName":"Anti-CD52","longName":"4000138","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD52 Monoclonal Antibody","conceptCode":"C72960","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD52, regardless of the antibody type (e.g., rat, mouse, humanized).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-B01B-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0B9CC03-3267-2938-E040-BB89AD433246","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-01-24","modifiedBy":"ONEDATA","dateModified":"2014-01-24","deletedIndicator":"No"},{"value":"Anti CD8","valueDescription":"Anti-CD8 Monoclonal Antibody","ValueMeaning":{"publicId":"4000131","version":"1","preferredName":"Anti-CD8 Monoclonal Antibody","longName":"4000131","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD8, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD8 Monoclonal Antibody","conceptCode":"C112888","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD8, regardless of the antibody type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AF07-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AF20-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD7","valueDescription":"Anti-CD7 Monoclonal Antibody","ValueMeaning":{"publicId":"4000132","version":"1","preferredName":"Anti-CD7 Monoclonal Antibody","longName":"4000132","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD7, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD7 Monoclonal Antibody","conceptCode":"C112887","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD7, regardless of the antibody type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AF2C-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AF45-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD6","valueDescription":"Anti-CD6 Monoclonal Antibody","ValueMeaning":{"publicId":"4000133","version":"1","preferredName":"Anti-CD6 Monoclonal Antibody","longName":"4000133","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD6, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD6 Monoclonal Antibody","conceptCode":"C112886","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD6, regardless of the antibody type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AF51-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AF6A-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD5","valueDescription":"Anti-CD5 Monoclonal Antibody","ValueMeaning":{"publicId":"4000134","version":"1","preferredName":"Anti-CD5 Monoclonal Antibody","longName":"4000134","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD5, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD5 Monoclonal Antibody","conceptCode":"C112885","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD5, regardless of the antibody type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AF76-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AF8F-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD4","valueDescription":"Anti-CD4 Monoclonal Antibody","ValueMeaning":{"publicId":"4000135","version":"1","preferredName":"Anti-CD4 Monoclonal Antibody","longName":"4000135","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD4, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD4 Monoclonal Antibody","conceptCode":"C112884","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD4, regardless of the antibody type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AF9B-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AFB4-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD3","valueDescription":"Anti-CD3 Monoclonal Antibody","ValueMeaning":{"publicId":"4000136","version":"1","preferredName":"Anti-CD3 Monoclonal Antibody","longName":"4000136","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD3, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD3 Monoclonal Antibody","conceptCode":"C112883","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AFC0-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AFD9-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD2","valueDescription":"Anti-CD2 Monoclonal Antibody","ValueMeaning":{"publicId":"4000137","version":"1","preferredName":"Anti-CD2 Monoclonal Antibody","longName":"4000137","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD2, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD2 Monoclonal Antibody","conceptCode":"C112882","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD2, regardless of the antibody type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-AFE5-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-AFFE-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Anti CD19","valueDescription":"Anti-CD19 Monoclonal Antibody","ValueMeaning":{"publicId":"4000140","version":"1","preferredName":"Anti-CD19 Monoclonal Antibody","longName":"4000140","preferredDefinition":"Any monoclonal antibody directed against the cell surface glycoprotein CD19, regardless of the antibody type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD19 Monoclonal Antibody","conceptCode":"C112889","definition":"Any monoclonal antibody directed against the cell surface glycoprotein CD19.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-B065-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED6ADBCA-B07E-7253-E040-BB89AD4343E9","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"ONEDATA","dateModified":"2013-12-13","deletedIndicator":"No"},{"value":"Alpha/beta antibody","valueDescription":"Alpha-Beta T-Cell Receptor Antibody","ValueMeaning":{"publicId":"4000139","version":"1","preferredName":"Alpha-Beta T-Cell Receptor Antibody","longName":"4000139","preferredDefinition":"Any monoclonal antibody directed against an alpha-beta T-Cell receptor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-Beta T-Cell Receptor Antibody","conceptCode":"C112909","definition":"Any monoclonal antibody directed against an alpha-beta T-Cell receptor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6ADBCA-B040-7253-E040-BB89AD4343E9","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FFF87EAE-15FB-E546-E040-BB89AD4332E2","beginDate":"2013-12-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-08-06","modifiedBy":"ONEDATA","dateModified":"2014-08-06","deletedIndicator":"No"},{"value":"Anti CD45RA","valueDescription":"Anti-CD45RA Monoclonal Antibody","ValueMeaning":{"publicId":"6681825","version":"1","preferredName":"Anti-CD45RA Monoclonal Antibody","longName":"6681825","preferredDefinition":"Any monoclonal antibody that recognizes receptor-type tyrosine-protein phosphatase C isoform CD45RA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD45RA Monoclonal Antibody","conceptCode":"C158687","definition":"Any monoclonal antibody that recognizes receptor-type tyrosine-protein phosphatase C isoform CD45RA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85181FEE-0BA0-2E53-E053-F662850AA35C","latestVersionIndicator":"Yes","beginDate":"2019-03-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-03-28","modifiedBy":"ONEDATA","dateModified":"2019-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85181FEE-0BB9-2E53-E053-F662850AA35C","beginDate":"2019-03-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-03-28","modifiedBy":"ONEDATA","dateModified":"2019-03-28","deletedIndicator":"No"},{"value":"Anti CD34","valueDescription":"Anti-CD34 Monoclonal Antibody","ValueMeaning":{"publicId":"6681826","version":"1","preferredName":"Anti-CD34 Monoclonal Antibody","longName":"6681826","preferredDefinition":"Any monoclonal antibody that recognizes hematopoietic progenitor cell antigen CD34.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-CD34 Monoclonal Antibody","conceptCode":"C158686","definition":"Any monoclonal antibody that recognizes hematopoietic progenitor cell antigen CD34.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85181FEE-0BC5-2E53-E053-F662850AA35C","latestVersionIndicator":"Yes","beginDate":"2019-03-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-03-28","modifiedBy":"ONEDATA","dateModified":"2019-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85181FEE-0BDE-2E53-E053-F662850AA35C","beginDate":"2019-03-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-03-28","modifiedBy":"ONEDATA","dateModified":"2019-03-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3976691","version":"1","preferredName":"Antibody Type","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.:Something distinguishable as an identifiable class based on common qualities.","longName":"C16295:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECB94912-46F3-A389-E040-BB89AD434D76","latestVersionIndicator":"Yes","beginDate":"2013-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-04","modifiedBy":"ONEDATA","dateModified":"2013-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECB94912-4704-A389-E040-BB89AD434D76","latestVersionIndicator":"Yes","beginDate":"2013-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-04","modifiedBy":"KUMMEROA","dateModified":"2019-03-28","changeDescription":". Added 2 PVs for 2006r5. AK 3/28/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"inf_proc_prod_manip_ab_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What antibodies were administ","type":"Preferred Question Text","description":"What antibodies were administered during the graft alteration?","url":null,"context":"NHLBI"},{"name":"What antibodies were used during product manipulation?","type":"Alternate Question Text","description":"What antibodies were used during product manipulation?","url":null,"context":"NHLBI"},{"name":"Specify antibodies used","type":"Alternate Question Text","description":"Specify antibodies used","url":null,"context":"NHLBI"},{"name":"Specify antibodies used","type":"Application Standard Question Text","description":"Specify antibodies used","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ECB94912-473E-A389-E040-BB89AD434D76","latestVersionIndicator":"Yes","beginDate":"2013-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-04","modifiedBy":"KUMMEROA","dateModified":"2019-07-11","changeDescription":".Added AQT/ASQT for 2006r5. AK 3/26/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}